Drug Type Chemical drugs |
Synonyms + [3] |
Target |
Mechanism ADAR inhibitors(adenosine deaminase RNA specific inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Avammune Therapeutics, Inc.Startup |
Active Organization Avammune Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | US | Avammune Therapeutics, Inc.Startup | 13 Jun 2024 |
Solid tumor | Preclinical | US | Avammune Therapeutics, Inc.Startup | 13 Jun 2024 |